The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt or stereoisomer thereof, to pharmaceutical compositions comprising said compound, and to their use in the treatment and/or prevention of epilepsy or neuropathic pain.

N-bridged diazocine analogues of carbamazepine to control neuronal activity with light and applications thereof / P. Gorostiza Langa, C. Matera, L. Camerin, F. Riefolo, G. Malieieva, A. Gomila Juaneda.

N-bridged diazocine analogues of carbamazepine to control neuronal activity with light and applications thereof

C. Matera;F. Riefolo;
2024

Abstract

The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt or stereoisomer thereof, to pharmaceutical compositions comprising said compound, and to their use in the treatment and/or prevention of epilepsy or neuropathic pain.
Institucio Catalana de Recerca i Estudis Avancats ICREA
Fundacio Institut de Bioenginyeria de Catalunya IBEC
Centro de Investigacion Biomedica en Red CIBER
EP 4427807 A1
EP 23382211.3
EP 23382211.3
11-set-2024
Settore CHEM-07/A - Chimica farmaceutica
N-bridged diazocine analogues of carbamazepine to control neuronal activity with light and applications thereof / P. Gorostiza Langa, C. Matera, L. Camerin, F. Riefolo, G. Malieieva, A. Gomila Juaneda.
File in questo prodotto:
File Dimensione Formato  
EP4427807A1.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Licenza: Nessuna licenza
Dimensione 1.35 MB
Formato Adobe PDF
1.35 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1179477
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact